Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).:
SEC Accession No. 0001370368-22-000012
Filing Date
2022-02-02
Accepted
2022-02-02 07:34:55
Documents
2

Document Format Files

Seq Description Document Type Size
1 IRANNOTICE a220202IRAN.htm IRANNOTICE 6369
2 logo.jpg GRAPHIC 26773
  Complete submission text file 0001370368-22-000012.txt   43997
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filer) CIK: 0001114448 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: IRANNOTICE | Act: 34 | File No.: 001-15024 | Film No.: 22581556
SIC: 2834 Pharmaceutical Preparations